Copyright Reports & Markets. All rights reserved.

Global In-Vitro Diagnostics Market - Premium Insight, Industry Trends, FPNV Positioning Matrix, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2024 (Q3 2018 Update)

Buy now

Table of Contents

    1. Preface

    • 1.1. Objectives of the Study
    • 1.2. Market Segmentation & Coverage
    • 1.3. Years Considered for the Study
    • 1.4. Currency & Pricing
    • 1.5. Stakeholders

    2. Research & Forecasting

    • 2.1. Research Methodology
      • 2.1.1. Research Instruments
        • 2.1.1.1. Secondary Instrument
        • 2.1.1.2. Primary Instrument
      • 2.1.2. Research Approaches
        • 2.1.2.1. Bottom-up Approach
        • 2.1.2.2. Top-down Approach
      • 2.1.3. Research Reliability & Validity
      • 2.1.4. Research Assumptions
      • 2.1.5. Vendor Inclusion Criteria
    • 2.2. Forecasting Methodology
      • 2.2.1. Methodology for Market Estimation & Forecasting
      • 2.2.2. Significance and Importance of the Market Estimation & Forecasting

    3. Executive Summary

      4. Premium Insight

      • 4.1. Market Connectivity
      • 4.2. Market Data Feed
      • 4.3. Market Vendor Ranking Analysis
      • 4.4. Market Dynamics
        • 4.4.1. Drivers
          • 4.4.1.1. Geriatric population and prevalence of chronic and infectious diseases in Americas
          • 4.4.1.2. Growing awareness on self-testing and personalized medicine
          • 4.4.1.3. Increasing adoption automated instruments and equipment in laboratories
          • 4.4.1.4. Increasing deployment of Point-of-Care testing facilities
        • 4.4.2. Restraints
          • 4.4.2.1. Unfavourable reimbursement
        • 4.4.3. Opportunities
          • 4.4.3.1. Development of condition-specific markers and tests
          • 4.4.3.2. Attractive companion diagnostics
          • 4.4.3.3. Growth opportunities in emerging countries
        • 4.4.4. Challenges
          • 4.4.4.1. Changing regulatory landscape
          • 4.4.4.2. Operational limitations faced in conducting diagnostic tests
      • 4.5. Porter’s Five Forces Analysis
        • 4.5.1. Threat of New Entrants
        • 4.5.2. Threat of Substitutes
        • 4.5.3. Bargaining Power of Customers
        • 4.5.4. Bargaining Power of Suppliers
        • 4.5.5. Industry Rivalry
      • 4.6. Microfluidics-Based POC and LOC Diagnostic Devices for Laboratory Testing
      • 4.7. Reagent Rental Agreements
      • 4.8. Regulatory Framework

      5. Global In-Vitro Diagnostics Market, by Component

      • 5.1. Introduction
      • 5.2. Data Management Software
      • 5.3. Instruments
      • 5.4. Reagents & Kits
      • 5.5. Services

      6. Global In-Vitro Diagnostics Market, by Technology

      • 6.1. Introduction
      • 6.2. Clinical Chemistry
        • 6.2.1. Basic Metabolic Panel
        • 6.2.2. Electrolyte Panel
        • 6.2.3. Lipid Profile
        • 6.2.4. Liver Panel
        • 6.2.5. Renal Profile
        • 6.2.6. Specialty Chemical Tests
        • 6.2.7. Thyroid Function Panel
      • 6.3. Coagulation & Hemostasis
      • 6.4. Hematology
      • 6.5. Immunochemistry
        • 6.5.1. Enzyme-Linked Immunosorbent Assay
          • 6.5.1.1. Chemiluminescence Immunoassays
          • 6.5.1.2. Colorimetric Immunoassays
          • 6.5.1.3. Fluorescence Immunoassays
        • 6.5.2. Enzyme-Linked Immunospot Assays
        • 6.5.3. Radioimmunoassay
        • 6.5.4. Rapid Test
        • 6.5.5. Western Blotting
      • 6.6. Microbiology
      • 6.7. Molecular Diagnostics
        • 6.7.1. DNA Sequencing & Next-Generation Sequencing
        • 6.7.2. Hybridization
        • 6.7.3. Isothermal Nucleic Acid Amplification Technology
        • 6.7.4. Microarray
        • 6.7.5. Polymerase Chain Reaction
      • 6.8. Urinalysis

      7. Global In-Vitro Diagnostics Market, by End User

      • 7.1. Introduction
      • 7.2. Hospitals & Care Providers
      • 7.3. Laboratories
      • 7.4. Patient Self-Testing

      8. Global In-Vitro Diagnostics Market, by Application

      • 8.1. Introduction
      • 8.2. Autoimmune Diseases
      • 8.3. Cardiology
      • 8.4. Diabetes
      • 8.5. Drug Testing
      • 8.6. HIV/Aids
      • 8.7. Infectious Diseases
      • 8.8. Nephrology
      • 8.9. Oncology

      9. Global In-Vitro Diagnostics Market, by Geography

      • 9.1. Introduction
      • 9.2. Americas In-Vitro Diagnostics Market
        • 9.2.1. Americas In-Vitro Diagnostics Market, by Country
          • 9.2.1.1. United States
          • 9.2.1.2. Brazil
          • 9.2.1.3. Canada
          • 9.2.1.4. Mexico
          • 9.2.1.5. Argentina
        • 9.2.2. Americas In-Vitro Diagnostics Market, by Component
        • 9.2.3. Americas In-Vitro Diagnostics Market, by Technology
        • 9.2.4. Americas In-Vitro Diagnostics Market, by End User
        • 9.2.5. Americas In-Vitro Diagnostics Market, by Application
      • 9.3. Europe, Middle East & Africa In-Vitro Diagnostics Market
        • 9.3.1. Europe, Middle East & Africa In-Vitro Diagnostics Market, by Country
          • 9.3.1.1. United Kingdom
          • 9.3.1.2. Germany
          • 9.3.1.3. France
          • 9.3.1.4. Saudi Arabia
          • 9.3.1.5. United Arab Emirates
          • 9.3.1.6. Italy
          • 9.3.1.7. Russia
        • 9.3.2. Europe, Middle East & Africa In-Vitro Diagnostics Market, by Component
        • 9.3.3. Europe, Middle East & Africa In-Vitro Diagnostics Market, by Technology
        • 9.3.4. Europe, Middle East & Africa In-Vitro Diagnostics Market, by End User
        • 9.3.5. Europe, Middle East & Africa In-Vitro Diagnostics Market, by Application
      • 9.4. Asia-Pacific In-Vitro Diagnostics Market
        • 9.4.1. Asia-Pacific In-Vitro Diagnostics Market, by Country
          • 9.4.1.1. China
          • 9.4.1.2. Japan
          • 9.4.1.3. India
          • 9.4.1.4. Australia
        • 9.4.2. Asia-Pacific In-Vitro Diagnostics Market, by Component
        • 9.4.3. Asia-Pacific In-Vitro Diagnostics Market, by Technology
        • 9.4.4. Asia-Pacific In-Vitro Diagnostics Market, by End User
        • 9.4.5. Asia-Pacific In-Vitro Diagnostics Market, by Application

      10. Competitive Strategic Window

      • 10.1. Introduction
        • 10.1.1. Leverage Zone
        • 10.1.2. Vantage Zone
        • 10.1.3. Speculative Zone
        • 10.1.4. Bottleneck Zone

      11. FPNV Positioning Matrix

      • 11.1. Introduction
      • 11.2. Scores
        • 11.2.1. Forefront
        • 11.2.2. Pathfinders
        • 11.2.3. Niche
        • 11.2.4. Vital
      • 11.3. Business Strategy
      • 11.4. Product Satisfaction

      12. Competitive News Feed Analysis

        13. Company Usability Profiles

        • 13.1. Abbott Laboratories, Inc.
        • 13.2. Agilent Technologies
        • 13.3. Arkray, Inc.
        • 13.4. Becton, Dickinson and Company
        • 13.5. Bio-Rad Laboratories, Inc.
        • 13.6. Biomérieux Sa
        • 13.7. Danaher Corporation
        • 13.8. Diasorin
        • 13.9. Johnson & Johnson
        • 13.10. Ortho Clinical Diagnostics
        • 13.11. Qiagen
        • 13.12. Roche Diagnostics
        • 13.13. Siemens AG
        • 13.14. Sysmex Corporation
        • 13.15. Thermo Fisher Scientific

        14. Appendix

        • 14.1. Top Reports
        • 14.2. Author Details

        LIST OF TABLES (50 TABLES)

          TABLE 1. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, 2016 - 2024 (USD BILLION)

            TABLE 2. GLOBAL IN-VITRO DIAGNOSTICS MARKET RANKING, BY VENDORS, 2017

              TABLE 3. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2016 - 2024 (USD BILLION)

                TABLE 4. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)

                  TABLE 5. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)

                    TABLE 6. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)

                      TABLE 7. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)

                        TABLE 8. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2016 - 2024 (USD BILLION)

                          TABLE 9. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)

                            TABLE 10. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY COAGULATION & HEMOSTASIS, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)

                              TABLE 11. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)

                                TABLE 12. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY IMMUNOCHEMISTRY, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)

                                  TABLE 13. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGY, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)

                                    TABLE 14. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)

                                      TABLE 15. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY URINALYSIS, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)

                                        TABLE 16. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2016 - 2024 (USD BILLION)

                                          TABLE 17. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)

                                            TABLE 18. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY LABORATORIES, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)

                                              TABLE 19. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT SELF-TESTING, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)

                                                TABLE 20. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2016 - 2024 (USD BILLION)

                                                  TABLE 21. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)

                                                    TABLE 22. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY CARDIOLOGY, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)

                                                      TABLE 23. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DIABETES, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)

                                                        TABLE 24. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DRUG TESTING, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)

                                                          TABLE 25. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HIV/AIDS, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)

                                                            TABLE 26. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)

                                                              TABLE 27. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY NEPHROLOGY, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)

                                                                TABLE 28. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)

                                                                  TABLE 29. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)

                                                                    TABLE 30. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, 2016 - 2024 (USD BILLION)

                                                                      TABLE 31. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2016 - 2024 (USD BILLION)

                                                                        TABLE 32. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2016 - 2024 (USD BILLION)

                                                                          TABLE 33. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2016 - 2024 (USD BILLION)

                                                                            TABLE 34. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2016 - 2024 (USD BILLION)

                                                                              TABLE 35. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, 2016 - 2024 (USD BILLION)

                                                                                TABLE 36. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2016 - 2024 (USD BILLION)

                                                                                  TABLE 37. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2016 - 2024 (USD BILLION)

                                                                                    TABLE 38. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2016 - 2024 (USD BILLION)

                                                                                      TABLE 39. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2016 - 2024 (USD BILLION)

                                                                                        TABLE 40. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, 2016 - 2024 (USD BILLION)

                                                                                          TABLE 41. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2016 - 2024 (USD BILLION)

                                                                                            TABLE 42. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2016 - 2024 (USD BILLION)

                                                                                              TABLE 43. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2016 - 2024 (USD BILLION)

                                                                                                TABLE 44. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2016 - 2024 (USD BILLION)

                                                                                                  TABLE 45. 360IRESEARCH SCORES FOR FOREFRONT IN IN-VITRO DIAGNOSTICS MARKET

                                                                                                    TABLE 46. 360IRESEARCH SCORES FOR PATHFINDERS IN IN-VITRO DIAGNOSTICS MARKET

                                                                                                      TABLE 47. 360IRESEARCH SCORES FOR NICHE IN IN-VITRO DIAGNOSTICS MARKET

                                                                                                        TABLE 48. 360IRESEARCH SCORES FOR VITAL IN IN-VITRO DIAGNOSTICS MARKET

                                                                                                          TABLE 49. 360IRESEARCH FPNV POSITIONING MATRIX BUSINESS STRATEGY FOR IN-VITRO DIAGNOSTICS MARKET

                                                                                                            TABLE 50. 360IRESEARCH FPNV POSITIONING MATRIX PRODUCT SATISFACTION FOR IN-VITRO DIAGNOSTICS MARKET

                                                                                                              LIST OF FIGURES (44 TABLES)

                                                                                                                FIGURE 1. GLOBAL IN-VITRO DIAGNOSTICS MARKET: YEARS CONSIDERED FOR THE STUDY

                                                                                                                  FIGURE 2. GLOBAL IN-VITRO DIAGNOSTICS MARKET: KEY RESEARCH METHODOLOGY

                                                                                                                    FIGURE 3. GLOBAL IN-VITRO DIAGNOSTICS MARKET: KEY RESEARCH INSTRUMENTS

                                                                                                                      FIGURE 4. GLOBAL IN-VITRO DIAGNOSTICS MARKET: KEY SECONDARY INSTRUMENT SOURCES

                                                                                                                        FIGURE 5. GLOBAL IN-VITRO DIAGNOSTICS MARKET: KEY POTENTIAL RESPONDENTS

                                                                                                                          FIGURE 6. GLOBAL IN-VITRO DIAGNOSTICS MARKET: KEY BREAKDOWN OF PRIMARY INSTRUMENT

                                                                                                                            FIGURE 7. GLOBAL IN-VITRO DIAGNOSTICS MARKET: KEY RESEARCH APPROACHES

                                                                                                                              FIGURE 8. GLOBAL IN-VITRO DIAGNOSTICS MARKET: KEY DATA TRIANGULATION

                                                                                                                                FIGURE 9. GLOBAL IN-VITRO DIAGNOSTICS MARKET: KEY RESEARCH ASSUMPTIONS

                                                                                                                                  FIGURE 10. IN-VITRO DIAGNOSTICS MARKET: KEY MARKET CONNECTIVITY

                                                                                                                                    FIGURE 11. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, 2016 - 2024 (USD BILLION)

                                                                                                                                      FIGURE 12. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2017 VS 2024 (USD BILLION)

                                                                                                                                        FIGURE 13. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)

                                                                                                                                          FIGURE 14. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)

                                                                                                                                            FIGURE 15. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)

                                                                                                                                              FIGURE 16. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)

                                                                                                                                                FIGURE 17. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017 VS 2024 (USD BILLION)

                                                                                                                                                  FIGURE 18. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)

                                                                                                                                                    FIGURE 19. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY COAGULATION & HEMOSTASIS, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)

                                                                                                                                                      FIGURE 20. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)

                                                                                                                                                        FIGURE 21. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY IMMUNOCHEMISTRY, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)

                                                                                                                                                          FIGURE 22. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGY, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)

                                                                                                                                                            FIGURE 23. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)

                                                                                                                                                              FIGURE 24. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY URINALYSIS, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)

                                                                                                                                                                FIGURE 25. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2017 VS 2024 (USD BILLION)

                                                                                                                                                                  FIGURE 26. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)

                                                                                                                                                                    FIGURE 27. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY LABORATORIES, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)

                                                                                                                                                                      FIGURE 28. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT SELF-TESTING, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)

                                                                                                                                                                        FIGURE 29. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017 VS 2024 (USD BILLION)

                                                                                                                                                                          FIGURE 30. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)

                                                                                                                                                                            FIGURE 31. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY CARDIOLOGY, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)

                                                                                                                                                                              FIGURE 32. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DIABETES, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)

                                                                                                                                                                                FIGURE 33. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DRUG TESTING, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)

                                                                                                                                                                                  FIGURE 34. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HIV/AIDS, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)

                                                                                                                                                                                    FIGURE 35. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)

                                                                                                                                                                                      FIGURE 36. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY NEPHROLOGY, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)

                                                                                                                                                                                        FIGURE 37. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)

                                                                                                                                                                                          FIGURE 38. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2017 (USD BILLION)

                                                                                                                                                                                            FIGURE 39. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY COMPONENT, 2024

                                                                                                                                                                                              FIGURE 40. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024

                                                                                                                                                                                                FIGURE 41. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2024

                                                                                                                                                                                                  FIGURE 42. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2024

                                                                                                                                                                                                    FIGURE 43. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY GEOGRAPHY, 2024

                                                                                                                                                                                                      FIGURE 44. 360IRESEARCH FPNV POSITIONING MATRIX FOR IN-VITRO DIAGNOSTICS MARKET

                                                                                                                                                                                                      The global in-vitro diagnostics market is expected to grow from USD 62.77 billion 2017 to USD 92.62 billion by the end of 2024 at a Compound Annual Growth Rate (CAGR) of 5.71%.

                                                                                                                                                                                                      “Geriatric population and prevalence of chronic and infectious diseases in Americas
                                                                                                                                                                                                      is one of the factors largely attributing to the growth of in-vitro diagnostics market globally”

                                                                                                                                                                                                      The factors attributing to the growth of the market are geriatric population and prevalence of chronic and infectious diseases in americas, growing awareness on self-testing and personalized medicine, increasing adoption automated instruments and equipment in laboratories, and increasing deployment of point-of-care testing facilities. However, some factors such as and unfavourable reimbursement may hinder the market growth. The global in-vitro diagnostics market is expected to showcase the opportunities such as development of condition-specific markers and tests, attractive companion diagnostics, and growth opportunities in emerging countries. In the near future, the market may face the possible challenges in the growth due to changing regulatory landscape, and operational limitations faced in conducting diagnostic tests. However, the key players in the market are putting regressive efforts to provide innovative offerings and benchmark strategies in the global in-vitro diagnostics market market.

                                                                                                                                                                                                      On the basis of component, the global in-vitro diagnostics market is studied across Data Management Software, Instruments, Reagents & Kits, and Services.

                                                                                                                                                                                                      On the basis of technology, the global in-vitro diagnostics market is studied across Clinical Chemistry, Coagulation & Hemostasis, Hematology, Immunochemistry, Microbiology, Molecular Diagnostics, and Urinalysis.

                                                                                                                                                                                                      On the basis of end user, the global in-vitro diagnostics market is studied across Hospitals & Care Providers, Laboratories, and Patient Self-Testing.

                                                                                                                                                                                                      On the basis of application, the global in-vitro diagnostics market is studied across Autoimmune Diseases, Cardiology, Diabetes, Drug Testing, HIV/Aids, Infectious Diseases, Nephrology, and Oncology.

                                                                                                                                                                                                      On the basis of geography, the global in-vitro diagnostics market is studied across Americas, (United States, Brazil, Canada, Mexico, and Argentina) Europe, Middle East & Africa, (United Kingdom, Germany, France, Saudi Arabia, United Arab Emirates, Italy, and Russia) and Asia-Pacific (China, Japan, India, and Australia).

                                                                                                                                                                                                      “Abbott Laboratories, Inc.: The potential growing player for the global in-vitro diagnostics market”

                                                                                                                                                                                                      The key players profiled in the global in-vitro diagnostics market are Abbott Laboratories, Inc., Agilent Technologies, Arkray, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biomérieux Sa, Danaher Corporation, Diasorin, Johnson & Johnson, Ortho Clinical Diagnostics, Qiagen, Roche Diagnostics, Siemens AG, Sysmex Corporation, and Thermo Fisher Scientific.

                                                                                                                                                                                                      The report provides insights on the following pointers:
                                                                                                                                                                                                      1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the global in-vitro diagnostics market.
                                                                                                                                                                                                      2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the global in-vitro diagnostics market.
                                                                                                                                                                                                      3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the global in-vitro diagnostics market.
                                                                                                                                                                                                      4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the global in-vitro diagnostics market.
                                                                                                                                                                                                      5. Competitive Assessment & Intelligence: Provides exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the global in-vitro diagnostics market.

                                                                                                                                                                                                      Buy now